General MedicationsINJECTIONGeneric

CEFOXITIN

CEFOXITIN SODIUM

Standard Dose

EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview CEFOXITIN is listed in Drugs@FDA under application 065012 (ANDA).

Marketing status: Discontinued Active ingredient CEFOXITIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2007-11-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview CEFOXITIN is listed in Drugs@FDA under application 065012 (ANDA). Marketing status: Discontinued Active ingredient CEFOXITIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2007-11-26 00:00:00. Submission type: SUPPL.

Monitoring

• Review priority: STANDARD
• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.